M&A Deal Summary

Gen-Probe Acquires Tepnel Life Sciences

On April 8, 2009, Gen-Probe acquired life science company Tepnel Life Sciences from YFM Equity Partners for 93M GBP

Acquisition Highlights
  • This is Gen-Probe’s 1st transaction in the Life Science sector.
  • This is Gen-Probe’s largest (disclosed) transaction.
  • This is Gen-Probe’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2009-04-08
Target Tepnel Life Sciences
Sector Life Science
Buyer(s) Gen-Probe
Sellers(s) YFM Equity Partners
Deal Type Add-on Acquisition
Deal Value 93M GBP
Advisor(s) Halliwells LLP (Legal)

Target

Tepnel Life Sciences

Wythenshawe, United Kingdom
Tepnel Life Sciences is a UK-based international life sciences products and services group with two divisions, Molecular Diagnostics and Research Products & Services.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Gen-Probe

San Diego, California, United States
Category Company
Founded 1983
Sector Medical Products
DESCRIPTION

Gen-Probe, Inc., is a provider in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 2
Country (United Kingdom) 1 of 1
Year (2009) 1 of 1
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-16 Gti Diagnostics

Waukesha, Wisconsin, United States

GTI Diagnostics develops, manufactures and markets specialty test kits for the in vitro diagnostics industry. Its advanced proprietary products fulfill niche testing needs and are used in over 400 laboratories. GTI is an ISO-certified company and registered with the FDA as an In Vitro Diagnostic Manufacturer.

Buy $53M

Seller(S) 1

SELLER

YFM Equity Partners

Leeds, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1982
PE ASSETS 300M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

YFM Equity Partners is a private equity firm focused on growth oriented investments in UK-based companies. The Firm looks to invest up to £10 million to support a variety of established, growing, and profitable businesses. YFM Equity Partners was formed in 1982 and is based in Leeds, England.

DEAL STATS #
Overall 11 of 48
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 9 of 34
Country (United Kingdom) 11 of 47
Year (2009) 2 of 3
Size (of disclosed) 2 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-01 Images At Work

Salisbury, United Kingdom

Images At Work Ltd. is a supplier of workwear to public and private sector organisations.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-22 DxS

Manchester, United Kingdom

DxS Ltd. is a personalized healthcare company providing molecular diagnostics to aid doctors and drug companies in selecting safe and effective therapies for patients based on their molecular profiles (Companion diagnostics). DxS was formed in 2001 and is headquartered in Manchester, UK.

Sell $130M
Mergr

Product

Company

Legal